OakChart

Usana Health Sciences Inc

USNAConsumer Defensive·Packaged Foods·USA·Micro·NYSE·Nov 11 • 1:20 PM ET

12.95-0.15 (-1.15%)
2026-11-11 19:21 CET
Market cap
242.04 USD m
Revenue, TTM
905.58 USD m
Net income, TTM
-21.20 USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-1.15
P/E
-
Compare

Price

USNA against its 20, 50 and 200-day averages
2050200miss
12.5015.0017.5020.0022.50345K689KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26USNAclose 12.9520-day 14.3050-day 14.56200-day 17.7812.9552w high

45.1% under the 52-week high of 23.59 on 28 Jul 2026. 52-week low 12.57 on 18 Aug 2026. Last 15 sessions, 20.0% high to low

Profile

USNA
52-week range, 3% of the way up
12.5723.59

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

IndexRUT
Employees1570
IPOMay 30, 1996
Beta0.67
ATR, 14d0.72
Rel volume0.54
Short float8.05%
Insider own40.90%
Inst own58.71%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap239.27M
Enterprise Value103.69M
Income-21.20M
Sales905.58M
Book/sh28.51
Cash/sh9.68
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees1570
IPOMay 30, 1996

Ratios

P/E-
Forward P/E10.36
PEG-
P/S0.26
P/B0.45
P/C1.34
P/FCF15.02
EV/EBITDA1.42
EV/Sales0.11
Quick Ratio1.84
Current Ratio2.59
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.15
EPS next Y1.25
EPS next Q0.12
EPS this Y-71.50%
EPS next Y127.27%
EPS next 5Y-4.52%
EPS past 3/5Y-45.56% -37.06%
Sales past 3/5Y-2.51% -4.00%
EPS Y/Y TTM-228.47%
Sales Y/Y TTM-0.78%
EPS Q/Q15.74%
Sales Q/Q-3.64%
EarningsNov 03 AMC
EPS/Sales Surpr.-200.00% -5.30%

Ownership

Insider Own40.90%
Insider Trans-0.38%
Inst Own58.71%
Inst Trans4.40%
ROA-2.95%
ROE-4.02%
ROIC-4.03%
Gross Margin74.56%
Oper. Margin4.29%
Profit Margin-2.34%
SMA20-9.42%
SMA50-11.06%
SMA200-27.15%
Trades-

Technical

Shs Outstand18.48M
Shs Float10.92M
Short Float8.05%
Short Ratio4.30
Short Interest0.88M
52W High23.59 -45.10%
52W Low12.57 3.02%
Volatility7.63% 5.10%
ATR (14)0.72
RSI (14)33.69
Beta0.67
Rel Volume0.54
Avg Volume204.44K
Volume67,426

Performance

Perf Week-9.63%
Perf Month-16.24%
Perf Quarter-4.99%
Perf Half Y-26.46%
Perf YTD-34.03%
Perf Year-31.88%
Perf 3Y-71.39%
Perf 5Y-87.12%
Perf 10Y-79.58%
Recom3.00
Target Price22.00
Prev Close13.10
Price12.95
Change %-1.15%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jun 23, 2023InitiatedSSidotiBuy
Jul 07, 2022DowngradeJJefferiesHold → Underperform$78 → $53+309.3%
Apr 14, 2022InitiatedDDA DavidsonNeutral$86+564.1%
Dec 17, 2020InitiatedRROTH CapitalBuy$107+726.3%
Aug 22, 2019InitiatedJJefferiesHold$65+401.9%
Apr 16, 2019InitiatedTTigress FinancialBuy
Oct 25, 2018UpgradeSSidotiNeutral → Buy
Oct 24, 2018UpgradePPivotal Research GroupHold → Buy$135+942.5%
Apr 23, 2018DowngradePPivotal Research GroupBuy → Hold$95 → $95+633.6%
Feb 07, 2018ReiteratedPPivotal Research GroupBuy$80 → $95+633.6%

Peers

Mkt cap
TickerCompanyMkt cap
HLFHerbalife Ltd1.61B
NATRNature's Sunshine Products Inc179.44M
NUSNu Skin Enterprises Inc193.01M
LFVNLifevantage Corp60.87M
FTLFFitLife Brands Inc78.13M
MTEXMannatech Inc16.11M
PREPrenetics Global Limited298.19M
NAIINatural Alternatives International Inc5.98M
MEDMedifast Inc146.92M
BODIBeachbody Company Inc31.21M

Insider trading

latest 14 of 23
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Neidig BrentCHIEF COMMERCIAL OFFICERJun 16 '26Sale19.455,00297,3040Jun 18 12:14 PM
BRENT LOWELL NEIDIGOfficerJun 16 '26Proposed Sale19.455,00297,304Jun 16 05:15 PM
Neidig BrentCHIEF COMMERCIAL OFFICERJun 12 '26Sale20.151,60232,2805,911Jun 16 03:42 PM
Neidig BrentCHIEF COMMERCIAL OFFICERJun 15 '26Sale20.0090918,1855,002Jun 16 03:42 PM
BRENT LOWELL NEIDIGOfficerJun 15 '26Proposed Sale20.0190918,185Jun 15 06:08 PM
Jones Paul A.CHIEF PEOPLE OFFICERJun 08 '26Sale18.505,561102,8780Jun 08 06:10 PM
PAUL A JONESOfficerJun 08 '26Proposed Sale18.505,561102,878Jun 08 04:36 PM
Fleming John TurmanDirectorJun 01 '26Sale17.932,45043,9284,230Jun 01 04:36 PM
Jones Paul A.CHIEF PEOPLE OFFICERMay 28 '26Sale18.956,813129,1065,561May 29 01:39 PM
PAUL A JONESOfficerMay 28 '26Proposed Sale18.956,813129,106May 28 06:14 PM
IIEKKING G DOUGCHIEF FINANCIAL OFFICERMay 27 '26Sale18.755,360100,5130May 28 12:17 PM
GARY DOUGLAS HEKKINGOfficerMay 27 '26Proposed Sale18.755,360100,513May 27 04:59 PM
FULLER GILBERT ADirectorMay 22 '26Sale18.661,05719,7290May 26 11:37 AM
Foukas JoshuaCHIEF LEGAL OFFICERMay 07 '26Sale19.823,79175,1380May 08 01:24 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
VDCVanguard Consumer Staples ETFAUM: 8.36B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
IWNiShares Russell 2000 Value ETFAUM: 14.10B

News

latest 14 of 200
  • USANA Misses And Cuts Guidance Again As Hiya's Subscriber Rebound Collides With A Shrinking Core Customer Base (Earnings Whispers)
  • USANA Health: Q3 Earnings Snapshot (Associated Press)
  • USANA Health Sciences Reports Third Quarter 2026 Results (Business Wire)
  • USANA BiOmega Earns ConsumerLab Seal of Approval for Quality and Purity (PR Newswire)
  • As Thanksgiving Nears, USANA CEO Kevin Guest Urges All to Rethink What Success Really Means (PR Newswire)
  • USANA Needs Steady China Core To Offset Venture Brand Damage After Guidance Cut (Earnings Whispers)
  • USANA Schedules Third Quarter 2026 Earnings Release and Conference Call (Business Wire)
  • USANA Health Sciences and University of Utah Athletics Announce New Partnership (PR Newswire)
  • USANA CEO Kevin Guest Shares Three Ways to Celebrate International Music Day (PR Newswire)
  • Protein Pop Launches Protein Pop Balance, a Clear Prebiotic Soda with 15 Grams of Protein and 5 Grams of Fiber (PR Newswire)
  • USANA CEO Kevin Guest Calls on People to Find a Way to Serve Others, Then Act (PR Newswire)
  • USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix (PR Newswire)
  • Usana Health Sciences Inc (USNA) (Q2 2026) Earnings Call Highlights: Strategic Pivots Amidst ... (GuruFocus.com) -34.20%
  • USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-03-0.1100.110-0.300205.89217.421
2026Q22026-08-04-0.0700.430-1.157223.272351
2026Q12026-05-050.6100.4400.408250240.991
2025Q42026-02-170.6000.410-0.097226.2225.961
2025Q32025-10-22-0.150-0.150-0.357214213.881
2025Q22025-07-220.7400.5400.521235.85225.21
2025Q12025-04-220.7300.7000.493249.54243.041
2024Q42025-02-250.6400.4900.233213.61208.822
2024Q32024-10-220.5600.4850.556200205.772
2024Q22024-07-230.5400.5820.545212.87215.752
2024Q12024-04-300.8600.6900.857227.8226.842
2023Q42024-02-060.8700.5150.871221.08212.422
2023Q32023-10-240.5900.5930.586213.37212.82
2023Q22023-07-250.8900.6960.890238.2231.142
2023Q12023-04-250.9500.7660.951248.36240.221
2022Q42023-02-070.6600.3500.664227.96203.81

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY3.7503.9152.5301,0471,033
2018FY5.1605.1235.1221,1891,198
2019FY4.4103.9954.4061,0611,042
2020FY5.8605.4035.8651,1351,116
2021FY5.7305.5755.7271,1861,191
2022FY3.5903.2803.591998.6974.4
2023FY3.3002.9403.297921.01912.35
2024FY2.5902.4502.193854.5849.72
2025FY1.9301.7400.580925.26925.02
2026FY-0.550--899.08
2027FY-1.250--916.9
2028FY-1.680--949.24

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-04110219.7219.7219.7
2026Q4S2026-11-03100218.09218.09218.09
2026Q4S2026-10-19100218.09218.09218.09
2026Q4S2026-10-07101218.09218.09218.09
2026Q4S2026-08-05101217.06217.06217.06
2026Q4S2026-05-06100235.13235.13235.13
2026Q4S2026-05-04100236.23236.23236.23
2026Q4S2026-04-20101236.23236.23236.23
2026Q4S2026-03-20101236.39236.39236.39
2026Q4S2026-02-18101236.37236.37236.37
2026Q4S2026-01-14110242.47242.47242.47
2026Q4S2025-12-17110230.97230.97230.97
2026Q4S2025-11-11101224.11224.11224.11
2026Q4S2025-11-10101224.11224.11224.11

Estimate history

EPS, annual2.535.1224.4065.8655.7273.5913.2972.1930.579-1.1459
Period201720182019202020212022202320242025TTM
EPS, quarterly0.5560.2330.4930.521-0.357-0.0970.408-1.157-0.3
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1047.2651189.2481060.9021134.6441186.464998.601921.01854.503925.257905.58
Period201720182019202020212022202320242025TTM
Sales, quarterly200.221213.613249.539235.848213.67226.2250.218223.273205.885
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual24.02423.56721.65521.03819.39319.20619.1319.06418.28118.463
Period201720182019202020212022202320242025MRQ
Shares, quarterly19.05619.06418.78618.26218.27218.28118.45718.463-
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue905.58925.26854.50921.01998.601,186.461,134.641,060.901,189.25
Cost of Goods Sold Incl. D&A230.41233.41175.75189.40207.28230.93222.86202.03217.44
Gross Profit675.16691.84678.75731.62791.32955.53911.79858.87971.81
Selling, General and Administrative Excl. Other636.35640.98612.43638.54683.70785.34735.29712.68783.46
Research and Development-10.6911.5711.4511.5611.1110.6310.2610.24
Other Operating Expense-0.000.000.000.000.000.000.000.00
Operating Income38.8250.8666.3293.07107.61170.19176.49146.19188.35
Interest Expense0.400.840.280.260.190.060.510.070.04
Unusual Expense-13.430.000.000.000.000.00--
Net Income Before Taxes-0.0641.5376.35102.45108.62170.64177.95150.50191.51
Income Taxes29.4130.0534.2938.6639.2754.1453.2849.9765.29
Consolidated Net Income-29.4811.4842.0663.7969.35116.50124.66100.53126.22
Net Income From Continuing Operations-21.2010.7642.0363.7969.35116.50124.66100.53126.22
Net Income-21.2010.7642.0363.7969.35116.50124.66100.53126.22
EPS (Recurring)-1.151.092.193.303.595.735.864.415.12
EPS (Basic, Before Extraordinaries)-1.150.582.203.313.605.785.894.445.24
EPS (Diluted)-1.150.582.193.303.595.735.864.415.12
EBITDA73.2790.5688.55113.47129.02192.38199.00168.98205.08
Non-Operating Income (Expense)4.094.9410.319.641.200.511.964.373.19
Other After Tax Adjustments-0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-11.2011.5011.5310.6510.7410.6812.9212.18
Price To Earnings Ratio--12.6917.3413.4417.7213.1417.7423.02
Price To Sales Ratio0.300.390.801.131.031.741.441.722.38
Gross Margin74.5674.7779.4379.4479.2480.5480.3680.9681.72
Operating Margin4.295.507.7610.1110.7814.3415.5513.7815.84
Net Margin-2.341.164.926.936.949.8210.999.4810.61
Shares Outstanding-18.2819.0619.1319.2119.3921.0421.6623.57
Market Capitalization242.04242.04684.051,025.361,021.781,969.541,622.021,700.072,822.81

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue205.88223.27250.22226.20213.67235.85249.54213.61
Cost of Goods Sold Incl. D&A48.7256.0167.7157.9756.7357.9360.7842.55
Gross Profit157.17167.26182.50168.23156.94177.92188.75171.06
Selling, General and Administrative Excl. Other158.62158.12168.63150.98155.71161.20173.08162.85
Other Operating Expense-0.000.000.000.000.000.000.00
Operating Income-1.459.1413.8717.251.2216.7215.678.21
Interest Expense0.040.000.240.120.050.260.410.13
Unusual Expense-29.140.0013.430.000.000.000.00
Net Income Before Taxes-0.80-18.9015.464.181.7918.8216.7410.43
Income Taxes6.099.058.515.778.468.377.455.95
Consolidated Net Income-6.89-27.956.96-1.59-6.6610.449.294.48
Net Income From Continuing Operations-5.56-21.387.51-1.77-6.529.659.404.45
Net Income-5.56-21.387.51-1.77-6.529.659.404.45
EPS (Recurring)-0.30-0.050.410.42-0.360.520.490.23
EPS (Basic, Before Extraordinaries)-0.30-1.160.41-0.10-0.360.520.490.23
EPS (Diluted)-0.30-1.160.41-0.10-0.360.520.490.23
EBITDA3.7618.3123.6627.5410.7926.3225.9214.09
Non-Operating Income (Expense)0.681.101.830.480.622.361.482.35
Other After Tax Adjustments-0.000.000.000.000.000.000.00
Stock Option Compensation Expense-2.692.733.112.832.862.882.85
Price To Earnings Ratio-44.9131.2022.0515.2816.7212.3112.69
Price To Sales Ratio0.300.440.340.380.570.640.610.80
Gross Margin76.3474.9172.9474.3773.4575.4475.6480.08
Operating Margin-0.704.095.547.630.577.096.283.84
Net Margin-2.70-9.583.00-0.78-3.054.093.772.09
Shares Outstanding-18.4618.4618.2818.2718.2618.7919.06
Market Capitalization242.04394.19322.44358.85503.39568.56509.85684.05

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments158.38181.77330.42288.42239.83312.88234.83277.87247.13
Short Term Receivables9.118.227.207.217.167.428.7614.0313.46
Inventories102.6169.7361.4567.0998.3290.2268.9181.9562.92
Other Current Assets17.4018.5717.4918.5017.5312.6915.1118.4916.65
Total Current Assets287.49278.29416.56381.23362.85423.21327.61392.33340.16
Net Property, Plant & Equipment117.34115.74117.48117.77125.57128.39126.5092.03102.85
Total Investments and Advances2.862.742.832.9023.823.062.862.913.08
Long-Term Note Receivable-------0.006.73
Intangible Assets271.11295.9947.0249.8048.1148.1646.4848.6352.57
Deferred Tax Assets27.2119.6413.289.804.844.643.093.352.86
Other Assets36.9135.7835.5835.0512.5533.4210.4115.2211.02
Total Assets742.91748.19632.76596.55577.74640.89516.93554.46519.27
Short Term Debt Incl. Current Port. of LT Debt19.6529.018.066.897.088.628.320.000.00
Accounts Payable17.2611.9810.0711.0513.5118.2012.539.9511.79
Income Tax Payable3.693.713.304.975.197.766.2915.0512.28
Other Current Liabilities87.9694.9297.41120.92135.01133.50108.96123.68117.11
Total Current Liabilities128.56139.62118.84143.83160.79168.07136.10148.69141.18
Long Term Debt12.3110.195.146.8910.2112.8617.270.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities6.534.074.554.077.5012.0110.2813.3713.73
Other Liabilities9.247.977.027.284.116.301.571.261.15
Total Liabilities156.64161.86135.56162.08182.62199.24165.22163.32156.06
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.0054.220.000.000.000.000.000.000.00
Common Equity533.10532.11497.20434.47395.12441.65351.71391.15363.21
Total Shareholders Equity533.10586.33497.20434.47395.12441.65351.71391.15363.21
Accumulated Minority Interest53.170.000.000.000.000.000.000.000.00
Total Equity586.27586.33497.20434.47395.12441.65351.71391.15363.21
Total Liabilities & Stockholders Equity742.91748.19632.76596.55577.74640.89516.93554.46519.27
Book Value Per Share29.1627.9125.9922.6220.3720.9916.2416.6015.12
Tangible Book Value Per Share14.3312.3923.5320.0317.8918.7014.1014.5312.93
Full-Time Employees1,5701,7001,8001,9001,9781,9431,9091,9111,810
Price to Book Ratio0.461.282.182.484.973.674.847.094.89
Return on Assets1.446.0910.3811.8119.1221.5318.7723.5112.63
Return on Equity1.927.7613.6916.7227.8531.4327.0633.4718.17
Return on Invested Capital1.977.0512.7015.7128.7427.4327.2432.2717.22
Quick Ratio1.441.492.992.181.651.981.902.091.96
Current Ratio2.241.993.512.652.262.522.412.642.41

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-11.4842.0663.7969.35116.50124.66100.53126.22
Depreciation-39.7022.2320.3921.4122.1922.5123.0116.84
Deferred Taxes & Investment Tax Credit--7.13-6.74-2.75-7.18-2.97-2.42-3.630.70
Other Funds (Non Cash)-21.3816.4517.2113.4714.3615.1015.6216.10
Funds from Operations-65.4374.0098.6497.05150.09159.84135.52159.87
Extraordinary Item-0.000.000.000.000.000.000.000.00
Changes in Working Capital--43.08-13.00-28.006.85-28.860.56-8.79-7.75
Cash from Operating Activities-22.3560.9970.64103.90121.23160.40126.73152.12
Capital Expenditures--13.82-10.07-14.49-10.40-12.76-15.09-16.57-11.43
Net Assets From Acquisitions-0.00-203.340.00-6.530.000.000.00-
Sale of Fixed Assets and Businesses-3.900.060.010.010.010.010.020.38
Purchase or Sale of Investments--1.070.262.504.55-1.55-19.1563.54-62.80
Purchase of Investments--1.07-0.87-1.270.00-1.55-21.090.00-86.40
Sale Or Maturity of Investments-0.001.123.774.550.001.9463.5423.60
Other Uses-0.000.000.000.000.000.00-1.660.00
Other Sources-0.860.000.000.000.120.282.174.85
Cash from Investing Activities--10.12-213.09-11.97-12.37-14.19-33.9647.49-69.00
Cash Dividends Paid-0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)-0.00-0.000.000.000.000.000.00
Change in Capital Stock--27.51-9.44-11.60-25.38-177.84-57.03-150.00-105.38
Repurchase of Common Pref Stock--27.51-9.44-11.60-25.38-177.84-57.03-150.00-105.38
Sale of Common Pref Stock-0.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options-0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net--9.0022.220.790.000.00-0.05-0.070.00
Change in Long Term Debt--9.0022.220.790.000.00-0.05-0.070.00
Issuance of Long Term Debt-17.6023.691.5411.000.0059.954.930.00
Reduction of Long Term Debt--26.60-1.47-0.75-11.000.00-60.00-5.000.00
Net Financing Active Other Cash Flow--4.10-3.22-3.43-4.71-3.58-2.37-1.990.10
Other Financing Activities Uses--4.10-3.22-3.43-4.71-3.58-2.37-1.99-0.81
Cash from Financing Activities--40.609.55-14.24-30.09-181.41-59.44-152.05-105.28
Exchange Rate Effect-5.11-6.19-2.50-13.782.0911.25-1.72-11.14
Net Change in Cash--23.27-148.7441.9347.67-72.2878.2520.45-33.30
Free Cash Flow-8.5350.9256.1593.50108.46145.31110.16140.69
Price to Free Cash Flow-42.3513.4318.4710.9918.9811.2816.5720.14

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments178.91168.56162.75158.38145.35151.34
Short Term Receivables5.033.349.669.110.000.00
Inventories84.0886.3496.36102.6190.7883.27
Other Current Assets22.2222.8325.4717.4027.9327.26
Total Current Assets290.24281.07294.23287.49264.06261.87
Net Property, Plant & Equipment94.6094.2794.62117.3496.2196.53
Total Investments and Advances-22.9522.912.8622.8022.79
Intangible Assets229.67233.76267.03271.11282.45286.98
Deferred Tax Assets29.7929.5425.1627.2124.1626.43
Other Assets64.1741.6335.0236.9136.9139.93
Total Assets708.47703.21738.97742.91726.59734.53
Short Term Debt Incl. Current Port. of LT Debt0.000.0014.0019.650.000.00
Accounts Payable17.6615.4316.2317.2616.2217.90
Income Tax Payable---3.69--
Other Current Liabilities94.5990.2487.0187.96102.44103.73
Total Current Liabilities112.25105.67117.24128.56118.66121.62
Long Term Debt-0.000.0012.310.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities4.864.665.066.534.474.66
Other Liabilities21.2621.9021.889.2421.9122.68
Total Liabilities138.38132.24144.18156.64145.04148.97
Non-Equity Reserves-0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity526.76526.31543.55533.10528.07531.06
Total Shareholders Equity526.76526.31543.55533.10528.07531.06
Accumulated Minority Interest43.3344.6751.2453.1753.4854.50
Total Equity570.10570.97594.79586.27581.55585.56
Total Liabilities & Stockholders Equity708.47703.21738.97742.91726.59734.53
Book Value Per Share-28.5129.4529.1628.9029.08
Tangible Book Value Per Share-15.8514.9814.3313.4413.37
Full-Time Employees---1,570--
Price to Book Ratio0.460.720.600.680.951.08
Return on Assets-2.95-3.081.191.442.435.00
Return on Equity-4.02-4.191.651.923.206.54
Return on Invested Capital--4.061.38-0.33-1.241.82
Quick Ratio1.841.841.691.441.461.47
Current Ratio2.592.662.512.242.232.15

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income--27.956.96-1.59-6.6610.44
Depreciation-9.179.7910.299.579.60
Other Funds (Non Cash)-34.324.778.764.044.49
Funds from Operations-10.2123.6214.788.9716.69
Extraordinary Item-0.000.000.000.000.00
Changes in Working Capital-13.11-13.86-18.17-10.93-4.47
Cash from Operating Activities-23.329.76-3.39-1.9612.22
Capital Expenditures--3.15-2.65-2.79-3.20-5.03
Net Assets From Acquisitions-0.000.000.000.000.00
Sale of Fixed Assets and Businesses-0.010.053.900.000.00
Purchase or Sale of Investments-0.000.000.000.000.00
Purchase of Investments-0.000.000.000.000.00
Sale Or Maturity of Investments-0.000.000.000.000.00
Other Uses--0.920.000.000.000.00
Other Sources-0.000.000.000.000.86
Cash from Investing Activities--4.06-2.601.11-3.20-4.16
Cash Dividends Paid-0.000.000.000.000.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Change in Capital Stock-0.000.000.000.00-15.21
Repurchase of Common Pref Stock-0.000.000.000.00-15.21
Sale of Common Pref Stock-0.000.000.000.000.00
Proceedsfrom Stock Options-0.000.000.000.000.00
Issuance or Reduction of Debt, Net--14.000.0014.000.00-23.00
Change in Long Term Debt--14.000.0014.000.00-23.00
Issuance of Long Term Debt-5.004.0016.000.001.60
Reduction of Long Term Debt--19.00-4.00-2.000.00-24.60
Net Financing Active Other Cash Flow--0.03-3.64-0.55-0.98-0.40
Other Financing Activities Uses--0.03-3.64-0.55-0.98-0.40
Cash from Financing Activities--14.03-3.6413.45-0.98-38.61
Exchange Rate Effect-0.610.901.910.172.31
Net Change in Cash-5.854.4213.09-5.97-28.24
Free Cash Flow-20.167.11-6.18-5.167.19
Price to Free Cash Flow-24.96105.0841.6827.9211.32

Revenue breakdown

All Other2024: 8.55M 2025: 27.76M
Hiya Nutritional Supplements2025: 120.28M
Personal Care And Skincare2024: 51.27M 2025: 46.26M
USANA Foods2024: 51.27M 2025: 46.26M
USANA Nutritionals2024: 743.42M 2025: 684.69M
Americas and Europe2024: 171.52M 2025: 298.09M
China2024: 457.98M 2025: 424.54M
North Asia2024: 78.21M 2025: 70.63M
Southeast Asia Pacific2024: 146.80M 2025: 132.00M
All Other2024: 6.74M 2025: 17.83M
Core Nutritional2024: 845.79M 2025: 775.45M
Hiya2024: 1.97M 2025: 131.97M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-308.05%0.9M10.9M208.82K
2026-10-157.13%0.8M10.9M195.91K
2026-09-307.07%0.8M10.9M182.38K
2026-09-156.91%0.8M10.9M174.00K
2026-08-315.92%0.6M10.9M155.26K
2026-08-146.93%0.8M10.9M140.63K
2026-07-316.33%0.7M10.9M111.16K
2026-07-156.90%0.8M10.9M111.77K
2026-06-306.04%0.7M10.9M115.82K
2026-06-155.86%0.6M10.9M118.46K
2026-05-295.88%0.6M10.9M126.91K
2026-05-155.47%0.6M10.9M133.52K
2026-04-304.61%0.5M10.9M127.66K
2026-04-154.39%0.5M10.9M131.96K
2026-03-314.91%0.5M10.8M134.89K
2026-03-134.19%0.5M10.8M134.40K
2026-02-273.75%0.4M10.7M129.84K
2026-02-133.87%0.4M10.7M138.52K
2026-01-304.48%0.5M10.8M167.11K
2026-01-154.63%0.5M10.8M234.35K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.508.1013.000.0017.8420.000.000.990-0.0160.001
call5.005.6010.500.0012.6280.000.000.953-0.0520.002
call7.503.107.900.007.3940.000.000.926-0.0480.003
call10.000.655.500.005.3840.000.000.872-0.0410.004
call12.500.004.902.706.08910.000.000.609-0.1040.008
call15.000.000.150.650.89755.000.000.165-0.0250.005
call17.500.004.900.057.83944.000.000.648-0.3280.008
call20.000.004.900.508.4163.000.000.633-0.3570.008
call22.500.004.900.008.8950.000.000.622-0.3810.008
call25.000.004.900.002.6690.000.000.092-0.0500.003
call30.000.004.900.009.9710.000.000.601-0.4340.008
put2.500.000.050.005.3010.000.00-0.010-0.0150.001
put5.000.004.900.004.6200.000.00-0.047-0.0510.002
put7.500.004.900.002.9060.000.00-0.077-0.0470.003
put10.000.004.900.001.6680.000.00-0.130-0.0390.004
put12.500.100.400.170.75413.006.00-0.387-0.1070.008
put15.000.002.501.404.32812.000.00-0.829-0.0210.005
put17.502.056.904.004.7181.000.00-0.352-0.3260.008
put20.004.509.500.005.2720.000.00-0.886-0.0420.004
put22.507.0012.000.005.7720.000.00-0.918-0.0360.003
put25.009.5014.500.006.1790.000.00-0.908-0.0470.003
put30.0014.6019.500.006.7990.000.00-0.934-0.0410.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-038-KCurrent report2026-11-03SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-058-KCurrent report2026-10-05SEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-07-04SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-25SEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-25SEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-23SEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-23SEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-23SEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-23SEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-23SEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-23SEC
2026-07-274Statement of changes in beneficial ownership of securities2026-07-23SEC
2026-06-184Statement of changes in beneficial ownership of securities2026-06-16SEC
2026-06-16144Filing for proposed sale of securities under Rule 144.SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-15144Filing for proposed sale of securities under Rule 144.SEC
2026-06-1511-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-08144Filing for proposed sale of securities under Rule 144.SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-08SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-28SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-0600294.58K5
2026-0500324.49K4
2026-040000
2026-0300106.24K2
2026-020095.22K1
2026-010000
2025-120074.33K2
2025-110061.12K2

Institutional holders

Manager% owned
Nantahala Capital Management, LLC8.78%
BlackRock, Inc.8.42%
PZENA INVESTMENT MANAGEMENT LLC6.03%
RENAISSANCE TECHNOLOGIES LLC5.19%
DIMENSIONAL FUND ADVISORS LP4.44%
VANGUARD CAPITAL MANAGEMENT LLC2.64%
Creative Planning2.26%
AQR CAPITAL MANAGEMENT LLC2.21%
VANGUARD PORTFOLIO MANAGEMENT LLC1.97%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.47%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.90%
iShares Russell 2000 ETF1.57%
U.S. SMALL CAP VALUE PORTFOLIO1.21%
Avantis U.S. Small Cap Value ETF0.86%
Schwab Fundamental U.S. Small Company ETF0.78%
VANGUARD CONSUMER STAPLES INDEX FUND0.69%
Fidelity Small Cap Index Fund0.67%
VANGUARD EXTENDED MARKET INDEX FUND0.66%
iShares Russell 2000 Value ETF0.52%
PIMCO RAE US Small Fund0.50%

OakChart. USNA. Cached 15 minutes.